查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1824618

2025年臨床次世代定序（NGS）資料分析全球市場報告

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

臨床新一代定序 (NGS) 數據分析市場預計將在未來幾年內快速成長，到 2029 年將達到 82.4 億美元，複合年成長率為 18.8%。預測期內的成長可歸因於液態切片技術的日益普及、人工智慧在數據分析中的整合、精準醫療計劃的擴展、新型定序技術的出現以及對群體基因組學計劃的日益關注。預測期內的主要趨勢包括伴隨診斷的成長、分散式檢查模式的興起、雲端基礎解決方案的使用日益增多、NGS 在非侵入性產前檢測中的應用不斷擴展以及資料解讀標準化通訊協定的發展。

我們預測未來五年該市場將成長18.8%，較我們先前對該市場的預測略有下降0.8%。這一下降主要源自於美國與其他國家之間關稅的影響。徵收關稅可能會擾亂美國的基因組醫學，因為這會增加從芬蘭和丹麥進口的美國雲端基礎資訊平台和變異解讀軟體的成本，從而可能減緩精準腫瘤學的普及並提高分析成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，關稅的影響可能更為廣泛。

臨床新一代定序數據分析市場預計將在個人化醫療需求不斷成長的推動下實現成長。個人化醫療根據個人的基因、環境和生活方式因素量身定做，由於基因組技術的進步、疾病複雜性的增加、治療效果的改善以及醫療成本的上升，正日益受到關注。次世代定序(NGS) 資料分析在個人化醫療中發揮關鍵作用，有助於快速且準確地對多個基因定序，從而更好地了解個體的基因圖譜。例如，2022 年 10 月的數據顯示，基因檢測產品和個人化醫療數量顯著增加，其中個人化醫療在新藥認證中佔比顯著，凸顯了 NGS 數據分析在推動個人化醫療應用方面發揮的重要作用。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球臨床次世代定序 (NGS) 資料分析：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
  • 最終用途產業分析
  • 全球臨床次世代定序 (NGS) 數據分析市場：成長率分析
  • 全球臨床次世代定序 (NGS) 資料分析市場表現：規模與成長，2019-2024 年
  • 全球臨床次世代定序 (NGS) 資料分析市場預測：規模與成長，2024-2029 年，2034 年
  • 全球臨床次世代定序 (NGS) 資料分析：總目標市場 (TAM)

第6章 市場細分

  • 全球臨床次世代定序 (NGS) 資料分析市場（按解決方案和服務、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • NGS資料分析工具
  • NGS資料分析與定序服務
  • NGS儲存、管理與雲端運算平台
  • 平台
  • 全球臨床次世代定序 (NGS) 資料分析市場（按技術、效能和預測），2019-2024 年、2024-2029 年、2034 年
  • 邊合成邊定定序（SBS）
  • 奈米孔定序
  • 單分子即時（SMRT）定序
  • 其他技術
  • 全球臨床次世代定序 (NGS) 資料分析市場：按應用、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 診斷
  • 藥物發現與設計
  • 醫學研究
  • 其他用途
  • 全球臨床次世代定序 (NGS) 資料分析市場：按最終用戶、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 學術機構與研究中心
  • 生技公司
  • 生命科學技術供應商
  • 其他最終用戶
  • 全球臨床次世代定序 (NGS) 資料分析市場：按 NGS 資料分析工具細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 軟體平台
  • 數據解釋工具
  • 生物資訊學工具
  • 數據分析解決方案
  • 全球臨床次世代定序 (NGS) 資料分析市場：細分 NGS 資料分析和定序服務（按類型）、實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 定序服務
  • 數據分析服務
  • 諮詢服務
  • 研究和診斷服務
  • 全球臨床次世代定序 (NGS) 資料分析市場：按 NGS 儲存、管理和雲端運算平台（按類型）細分，實際和預測，2019-2024 年、2024-2029 年、2034 年
  • 資料儲存解決方案
  • 資料管理平台
  • 雲端基礎的平台
  • 雲端儲存服務
  • 全球臨床次世代定序 (NGS) 資料分析市場：按平台（類型）細分、效能和預測，2019-2024 年、2024-2029 年、2034 年
  • 定序平台
  • NGS儀器平台
  • 整合NGS平台

第7章 區域和國家分析

  • 全球臨床次世代定序 (NGS) 資料分析市場：區域分析、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 全球臨床次世代定序 (NGS) 資料分析市場：國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 臨床次世代定序 (NGS) 資料分析市場：競爭格局
  • 臨床次世代定序（NGS）資料分析市場：公司簡介
    • Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • PerkinElmer Inc.
  • Bio-Rad Laboratories Inc.
  • Qiagen
  • BGI Group
  • 10x Genomics
  • Genomic Health
  • Oxford Nanopore Technologies PLC
  • Pacific Biosciences of California Inc.
  • Sophia Genetics
  • Genewiz
  • Partek Inc.
  • DNAnexus
  • BioNano Genomics
  • PierianDx
  • GENAPSYS

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年臨床次世代定序（NGS）資料分析市場：提供新機會的國家
  • 2029年臨床次世代定序（NGS）資料分析市場：細分市場帶來新機會
  • 2029年臨床下一代定序（NGS）資料分析市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r27676u

Clinical next-generation sequencing (NGS) data analysis is the interpretation of genetic information acquired through advanced sequencing technologies within a clinical context. These technologies enable the rapid and cost-effective sequencing of large DNA or RNA samples, allowing for the identification of genetic variations associated with diseases or conditions. This analytical process is essential for comprehending the genetic underpinnings of diseases, supporting personalized medicine approaches, and guiding clinical decision-making.

The main types of solutions and services in clinical next-generation sequencing (NGS) data analysis encompass NGS data analysis tools, NGS data analysis and sequencing services, and NGS storage, management, and cloud computing platforms. NGS data analysis tools are software applications designed to interpret and process the vast amount of data generated through NGS technologies. Leveraging various sequencing technologies such as sequencing by synthesis (SBS), nanopore sequencing, and single-molecule real-time (SMRT) sequencing, these tools find applications in diagnostics, drug discovery, medical research, and other domains. End-users of these tools span hospitals, clinics, academic institutes, research centers, biotechnology companies, and life science technology vendors.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The clinical next-generation sequencing (NGS) data analysis market research report is one of a series of new reports from The Business Research Company that provides clinical next-generation sequencing (NGS) data analysis market statistics, including clinical next-generation sequencing (NGS) data analysis industry global market size, regional shares, competitors with a clinical next-generation sequencing (NGS) data analysis market share, detailed clinical next-generation sequencing (NGS) data analysis market segments, market trends and opportunities, and any further data you may need to thrive in the clinical next-generation sequencing (NGS) data analysis industry. This clinical next-generation sequencing (NGS) data analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The clinical next-generation sequencing (ngs) data analysis market size has grown exponentially in recent years. It will grow from $3.43 billion in 2024 to $4.14 billion in 2025 at a compound annual growth rate (CAGR) of 20.5%. The growth in the historic period can be attributed to research advancements in genomics, declining sequencing costs, growing demand for personalized medicine, expanding applications in clinical diagnostics, increasing prevalence of genetic diseases.

The clinical next-generation sequencing (ngs) data analysis market size is expected to see rapid growth in the next few years. It will grow to $8.24 billion in 2029 at a compound annual growth rate (CAGR) of 18.8%. The growth in the forecast period can be attributed to rising adoption of liquid biopsy techniques, integration of artificial intelligence in data analysis, expansion of precision medicine initiatives, emergence of novel sequencing technologies, increasing focus on population genomics initiatives. Major trends in the forecast period include growth of companion diagnostics, rise of decentralized testing models, increasing use of cloud-based solutions, expansion of NGS applications in non-invasive prenatal testing, development of standardized protocols for data interpretation.

The forecast of 18.8% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. genomic medicine by increasing costs for cloud-based bioinformatics platforms and variant interpretation software imported from Finland and Denmark, potentially slowing precision oncology implementation and raising analysis costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The clinical next-generation sequencing data analysis market is poised for growth, propelled by the rising demand for personalized medicines. Personalized medicine, tailored to individual genetic, environmental, and lifestyle factors, gains prominence due to genomic technologies, increasing disease complexity, improved treatment outcomes, and escalating healthcare costs. Next-generation sequencing (NGS) data analysis plays a pivotal role in personalized medicine, facilitating rapid and accurate sequencing of multiple genes, thereby enhancing understanding of an individual's genetic profile. For example, data from October 2022 reports a significant number of genetic testing products and personalized medicines, with personalized medicines accounting for a notable portion of new drug approvals, underlining the integral role of NGS data analysis in driving personalized medicine adoption.

Key players in the clinical NGS data analysis market are innovating to meet burgeoning demands for genomic analysis accuracy. Advanced solutions such as the NextSeq 2000 Sequencing System represent significant developments in this realm. This system comprises integrated hardware and software components designed to streamline DNA sequencing processes, offering precise nucleotide sequencing within DNA molecules. For instance, Illumina Inc.'s September 2022 launch of the NovaSeq X Series introduces a paradigm shift in production-scale sequencing, boasting enhanced speed, power, and sustainability. Leveraging innovative technology such as XLEAP-SBS chemistry and ultra-high density flow cells, the NovaSeq X Series offers substantially increased throughput and sequencing accuracy, meeting the escalating demands for genomic analysis.

In January 2023, QIAGEN NV, a Germany-based provider of molecular testing solutions, acquired Verogen Inc. for $150 million. The acquisition aims to strengthen QIAGEN's molecular testing and forensic genomics offerings by incorporating Verogen's next-generation sequencing (NGS) technology, which enhances capabilities in genetic analysis. Verogen Inc., a US-based company, specializes in NGS solutions focused on human identification (Human ID) and forensic applications.

Major companies operating in the clinical next-generation sequencing (NGS) data analysis market are Roche Diagnostics, Thermo Fisher Scientific Inc., Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Bio-Rad Laboratories Inc., Qiagen, BGI Group, 10x Genomics, Genomic Health, Oxford Nanopore Technologies PLC., Pacific Biosciences of California Inc., Sophia Genetics, Genewiz, Partek Inc., DNAnexus, BioNano Genomics, PierianDx, GENAPSYS, Nugen Technologies, DNAStar Inc., Swift Biosciences, Basepair, BioDatomics, Congenica Ltd., Theragen Etex Inc., Golden Helix Inc.

North America was the largest region in the clinical next-generation sequencing (NGS) data analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the clinical next-generation sequencing (NGS) data analysis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the clinical next-generation sequencing (NGS) data analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The clinical next-generation sequencing data analysis market consists of revenues earned by entities by providing services such as data preprocessing, alignment, variable calling, annotation, prioritization, interpretation, and reporting. The market value includes the value of related goods sold by the service provider or included within the service offering. The clinical next-generation sequencing data analysis market also includes sales of software tools, platforms, and pre-processing tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Clinical Next-Generation Sequencing (NGS) Data Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on clinical next-generation sequencing (ngs) data analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for clinical next-generation sequencing (ngs) data analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The clinical next-generation sequencing (ngs) data analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Solution And Services: NGS Data Analysis Tools; NGS Data Analysis And Sequencing Services; NGS Storage, Management And Cloud Computing Platform; Platforms
  • 2) By Technology: Sequencing By Synthesis (SBS); Nanopore Sequencing; Single-Molecule Real-Time (SMRT) Sequencing; Other Technologies
  • 3) By Application: Diagnostics; Drug Discovery And Designing; Medical Research; Other Applications
  • 4) By End User: Hospitals And Clinics; Academic Institutes And Research Centers; Biotechnology Companies; Life Science Technology Vendors; Other End Users
  • Subsegments:
  • 1) By NGS Data Analysis Tools: Software Platforms; Data Interpretation Tools; Bioinformatics Tools; Data Analytics Solutions
  • 2) By NGS Data Analysis And Sequencing Services: Sequencing Services; Data Analysis Services; Consultation Services; Research And Diagnostic Services
  • 3) By NGS Storage, Management, And Cloud Computing Platform: Data Storage Solutions; Data Management Platforms; Cloud-Based Platforms; Cloud Storage Services
  • 4) By Platforms: Sequencing Platforms; NGS Instrumentation Platforms; Integrated NGS Platforms
  • Companies Mentioned: Roche Diagnostics; Thermo Fisher Scientific Inc.; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; Bio-Rad Laboratories Inc.; Qiagen; BGI Group; 10x Genomics; Genomic Health; Oxford Nanopore Technologies PLC.; Pacific Biosciences of California Inc.; Sophia Genetics; Genewiz; Partek Inc.; DNAnexus; BioNano Genomics; PierianDx; GENAPSYS; Nugen Technologies; DNAStar Inc.; Swift Biosciences; Basepair; BioDatomics; Congenica Ltd.; Theragen Etex Inc.; Golden Helix Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Characteristics

3. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Trends And Strategies

4. Clinical Next-Generation Sequencing (NGS) Data Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Growth Rate Analysis
  • 5.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Total Addressable Market (TAM)

6. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Segmentation

  • 6.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • NGS Data Analysis Tools
  • NGS Data Analysis And Sequencing Services
  • NGS Storage, Management And Cloud Computing Platform
  • Platforms
  • 6.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing By Synthesis (SBS)
  • Nanopore Sequencing
  • Single-Molecule Real-Time (SMRT) Sequencing
  • Other Technologies
  • 6.3. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Diagnostics
  • Drug Discovery And Designing
  • Medical Research
  • Other Applications
  • 6.4. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Academic Institutes And Research Centers
  • Biotechnology Companies
  • Life Science Technology Vendors
  • Other End Users
  • 6.5. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis Tools, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software Platforms
  • Data Interpretation Tools
  • Bioinformatics Tools
  • Data Analytics Solutions
  • 6.6. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Data Analysis And Sequencing Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Services
  • Data Analysis Services
  • Consultation Services
  • Research And Diagnostic Services
  • 6.7. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of NGS Storage, Management, And Cloud Computing Platform, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Data Storage Solutions
  • Data Management Platforms
  • Cloud-Based Platforms
  • Cloud Storage Services
  • 6.8. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Sequencing Platforms
  • NGS Instrumentation Platforms
  • Integrated NGS Platforms

7. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Regional And Country Analysis

  • 7.1. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 8.1. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 9.1. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 9.2. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 10.1. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 11.1. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 11.2. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 12.1. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 13.1. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 14.1. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 14.2. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 15.1. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 15.2. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 16.1. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 17.1. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 18.1. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 19.1. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 20.1. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 21.1. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 21.2. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 22.1. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 23.1. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 23.2. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 24.1. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 24.2. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 25.1. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 25.2. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 26.1. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 26.2. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 27.1. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 28.1. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 28.2. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market

  • 29.1. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market Overview
  • 29.2. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Solution And Services, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Clinical Next-Generation Sequencing (NGS) Data Analysis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape And Company Profiles

  • 30.1. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Landscape
  • 30.2. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Company Profiles
    • 30.2.1. Roche Diagnostics Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Eurofins Scientific Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Clinical Next-Generation Sequencing (NGS) Data Analysis Market Other Major And Innovative Companies

  • 31.1. PerkinElmer Inc.
  • 31.2. Bio-Rad Laboratories Inc.
  • 31.3. Qiagen
  • 31.4. BGI Group
  • 31.5. 10x Genomics
  • 31.6. Genomic Health
  • 31.7. Oxford Nanopore Technologies PLC
  • 31.8. Pacific Biosciences of California Inc.
  • 31.9. Sophia Genetics
  • 31.10. Genewiz
  • 31.11. Partek Inc.
  • 31.12. DNAnexus
  • 31.13. BioNano Genomics
  • 31.14. PierianDx
  • 31.15. GENAPSYS

32. Global Clinical Next-Generation Sequencing (NGS) Data Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

34. Recent Developments In The Clinical Next-Generation Sequencing (NGS) Data Analysis Market

35. Clinical Next-Generation Sequencing (NGS) Data Analysis Market High Potential Countries, Segments and Strategies

  • 35.1 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Clinical Next-Generation Sequencing (NGS) Data Analysis Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer